Comparison of facility and home-based antiretroviral therapy delivery systems in Uganda

ISRCTN ISRCTN17184129
DOI https://doi.org/10.1186/ISRCTN17184129
Secondary identifying numbers 4371
Submission date
06/08/2005
Registration date
26/09/2005
Last edited
30/11/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Shabbar Jaffar
Scientific

London School of Hygiene and Tropical Medicine (LSHTM)
Keppel Street
London
WC1E 7HT
United Kingdom

Phone +44 (0)20 7927 2418
Email shabbar.jaffar@lshtm.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleComparison of facility and home-based antiretroviral therapy delivery systems in Uganda: a randomised controlled trial
Study objectivesThat home-based human immunodeficiency virus (HIV) care is approximately equivalent in effectiveness to facility-based HIV care.

As of 14/04/2009 this record was updated; all updates can be found under the relevant field. At this time, the anticipated end date was also amended; the initial anticipated end date was 15/02/2009.
Ethics approval(s)Added 14/04/2009:
1. London School of Hygiene and Tropical Medicine Ethics Committee approved on the 25th November 2004 (ref: 2058)
2. Uganda Virus Research Institute Science and Ethics Committee approved on the 20th August 2004 (ref: "A randomised trial of home or facility-based AIDS care")
3. US Centers for Disease Control and Prevention approved on the 18th January 2005 (ref: 4371)
Health condition(s) or problem(s) studiedHuman immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)
InterventionA comparison of two different ways of providing ART in an African setting - home-based versus facility-based HIV care
Intervention typeOther
Primary outcome measureTime to detectable viral load
Secondary outcome measures1. Adherence
2. Cost effectiveness
3. Treatment failure
Overall study start date15/02/2005
Completion date31/01/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants1000
Key inclusion criteriaAll HIV-infected adults (aged 18 years or more) who are started on antiretroviral therapy (ART) by a service provider (The acquired immunodeficiency syndrome [AIDS] Support Organisation) and who plan to remain in the study area for 12 months.
Key exclusion criteria1. Already on ART and transferred from another centre
2. Live on islands and are difficult to follow-up
Date of first enrolment15/02/2005
Date of final enrolment31/01/2009

Locations

Countries of recruitment

  • England
  • Uganda
  • United Kingdom

Study participating centre

London School of Hygiene and Tropical Medicine (LSHTM)
London
WC1E 7HT
United Kingdom

Sponsor information

Medical Research Council Unit on AIDS (Uganda)
Research council

c/o Uganda Virus Research Institute
P.O. Box 49
Entebbe
-
Uganda

Phone +256 (0)43 120 764
Email shabbar.jaffar@lshtm.ac.uk

Funders

Funder type

Research council

Centers for Disease Control (CDC) (USA) - Co-operative Agreement (ref: IU01-PS000065-01)

No information available

Medical Research Council (MRC) (UK)
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 01/11/2007 Yes No
Results article results 19/12/2009 Yes No